Mindfulness Walking Intervention to Enhance Resilience (iWalk)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-110
SponsorUniversity of Illinois at Urbana-Champaign
About this trial
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).
The objectives are to evaluate:
1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.
Eligibility criteria
Qualifiers
18 years or older,
clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
never received meditation training via coaching/certification/life coaching,
Disqualifiers
None
Trial design
Treatments tested in this trial
- iWalk Program
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov